Literature DB >> 8958336

Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families.

R M Hughes-Benzie1, G Pilia, J Y Xuan, A G Hunter, E Chen, M Golabi, J A Hurst, J Kobori, K Marymee, R A Pagon, H H Punnett, S Schelley, J L Tolmie, M M Wohlferd, T Grossman, D Schlessinger, A E MacKenzie.   

Abstract

Simpson-Golabi-Behmel syndrome (SGBS) is an X-linked overgrowth disorder recently shown to be caused by mutations in the heparan sulfate proteoglycan GPC3 [Pilia et al., Nat Genet; 12:241-247 1996]. We have used Southern blot analysis and polymerase chain reaction amplification of intra-exonic sequences to identify four new GPC3 mutations and further characterize three previously reported SGBS mutations. De novo GPC3 mutations were identified in 2 families. In general, the mutations were unique deletions ranging from less than 0.1 kb to more than 300 kb in length with no evidence of a mutational hot spot discerned. The lack of correlation between the phenotype of 18 affected males from these 7 families and the location and size of the GPC3 gene mutations suggest that SGBS is caused by a nonfunctional GPC3 protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958336     DOI: 10.1002/(SICI)1096-8628(19961211)66:2<227::AID-AJMG20>3.0.CO;2-U

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  19 in total

Review 1.  Glypicans: proteoglycans with a surprise.

Authors:  J Filmus; S B Selleck
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 2.  The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans.

Authors:  Jorge Filmus
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

3.  Transient QT interval prolongation in an infant with Simpson-Golabi-Behmel syndrome.

Authors:  Emily Gertsch; Salman Kirmani; Michael J Ackerman; Dusica Babovic-Vuksanovic
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

4.  Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.

Authors:  Bowen Liu; Aaron W Bell; Shirish Paranjpe; William C Bowen; Jaspal S Khillan; Jian-Hua Luo; Wendy M Mars; George K Michalopoulos
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes.

Authors:  J Eggenschwiler; T Ludwig; P Fisher; P A Leighton; S M Tilghman; A Efstratiadis
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

Review 6.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

7.  Epigenetic silencing of beta-spectrin, a TGF-beta signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome.

Authors:  Zhi-Xing Yao; Wilma Jogunoori; Sanaa Choufani; Asif Rashid; Tiffany Blake; Wenguo Yao; Peter Kreishman; Rupen Amin; Anton A Sidawy; Stephen R T Evans; Milton Finegold; E Premkumar Reddy; Bibhuti Mishra; Rosanna Weksberg; Rakesh Kumar; Lopa Mishra
Journal:  J Biol Chem       Date:  2010-08-25       Impact factor: 5.157

8.  Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.

Authors:  Bowen Liu; Shirish Paranjpe; William C Bowen; Aaron W Bell; Jian-Hua Luo; Yan-Ping Yu; Wendy M Mars; George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

9.  A survey of phenotypic features in juvenile polyposis.

Authors:  D C Desai; V Murday; R K Phillips; K F Neale; P Milla; S V Hodgson
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

10.  Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex.

Authors:  Vishakha S Bhave; Wendy Mars; Shashikiran Donthamsetty; Xiyue Zhang; Langzhu Tan; Jianhua Luo; William C Bowen; George K Michalopoulos
Journal:  Am J Pathol       Date:  2013-05-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.